Skip to content

8-KAccepted Nov 29, 6:02 AM ET

Revance Therapeutics, Inc. 8-K

Revance Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

6:02 AM

Nov 29, 2024

Filed

Nov 29, 2024

Documents

13

Size

198.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.